Scientists at Fred Hutch Cancer Center have reported an important advance in the effort to stop Epstein Barr virus (EBV), a ...

Over 95% of the world’s adult population is infected with Epstein–Barr virus (EBV), but most people never realise it. The ...

Researchers may be closer to developing a vaccine that protects against Epstein-Barr, a common virus linked with infectious ...

Fred Hutch Cancer Center scientists reached a crucial milestone in blocking Epstein Barr virus (EBV), a pathogen estimated to infect 95% of the global population that is linked to multiple types of ...

What starts with nonspecific symptoms like persistent fatigue, sore throat, and swollen lymph nodes—can lead to lifelong impacts on health. For many students, these symptoms are easy to attribute to ...

The Epstein-Barr virus (EBV) can cause certain types of cancer or autoimmune diseases, but how the body controls this common ...

The results of preclinical research headed by a team at Karolinska Institutet have indicated how T cells that play a role in the immune system’s reaction to the common Epstein-Barr virus (EBV) can ...

A type of immune cell targeting the Epstein-Barr virus may play a key role in driving multiple sclerosis (MS), a study found.